ACIP Final February 2011 Meeting Agenda by gdf57j

VIEWS: 17 PAGES: 2

									                                                           FINAL - February 16, 2011
                             MEETING OF THE ADVISORY COMMITTEE ON IMMUNIZATION PRACTICES (ACIP)
                                                       Centers for Disease Control and Prevention
                             1600 Clifton Road, NE, Tom Harkin Global Communications Center (Building 19), Atlanta, Georgia
                                                                  February 23-24, 2011
        AGENDA ITEM                                                    PURPOSE               PRESIDER/PRESENTER(s)

Wednesday, February 23, 2011
8:00   Welcome & Introductions                                                               Dr. Carol Baker (Chair, ACIP)
                                                                                             Dr. Larry Pickering (Executive Secretary, ACIP; CDC)

8:30     Pertussis
         · Introduction                                                                      Dr. Mark Sawyer (ACIP, WG Chair)
         · Brief update on pertussis surveillance 2010                 Information           Dr. Jennifer Liang (CDC/NCIRD)
         · Proposed recommendations on use of Tdap in
                                                                                             Dr. Jennifer Liang (CDC/NCIRD)
         healthcare personnel
                                                                          Vote
         · Proposed recommendation on use of post-exposure
                                                                                             Dr. Jennifer Liang (CDC/NCIRD)
         prophylaxis in healthcare personnel
         · Overview of Tdap use during pregnancy
             · Historical perspective and published literature        Information &          Dr. Tejpratap Tiwari (CDC/NCIRD)
             · Unpublished and recent data                                                   Dr. Jennifer Liang (CDC/NCIRD)
         · Considerations for use of Tdap in pregnant women            Discussion            Dr. Jennifer Liang (CDC/NCIRD)

10:30    Break

11:00    Japanese Encephalitis Vaccine
         · Introduction                                               Information &          Dr. Paul Cieslak (ACIP, WG Chair); Dr. Marc Fischer
                                                                        Discussion           (CDC/NCEZID)
         · Data supporting use of a booster dose                                             Dr. Katrin Dubischar-Kastner (Intercell)
         · Recommendations for use of a booster dose                      Vote               Dr. Marc Fischer (CDC/NCEZID)

11:30    Immunization of Healthcare Personnel (HCP)
         · Introduction                                               Information &          Ms. Kris Ehresmann (ACIP, WG Chair)
                                                                        Discussion
         · Immunization of HCP recommendations                                               Dr. Harry Keyserling (Emory University School of Medicine)
                                                                           Vote
12:05    Lunch

1:20     Immunization Safety Office Update: Vaccines and Febrile Seizures
         · Introduction and background                                                       Dr. Frank Destefano (CDC/NCEZID)
                                                                 Information
         · Febrile seizures in the Vaccine Safety Datalink (VSD)                             Dr. Grace Lee (Harvard Medical School)

2:20     Influenza
         · Introduction                                                                      Dr. Wendy Keitel (ACIP, WG Chair)
         · Epidemiology and surveillance update                                              Dr. Lisa Grohskopf (CDC/NCIRD)
         · Vaccine distribution/uptake                                                       Dr. Cindy Weinbaum (CDC/NCIRD)
                                                                      Information &
         · Antiviral guidance                                                                Dr. Tim Uyeki (CDC/NCIRD)
                                                                        Discussion
         · Influenza vaccines and egg allergies                                              Dr. Lisa Grohskopf (CDC/NCIRD)
         · Proposed recommendations                                                          Dr. Lisa Grohskopf (CDC/NCIRD)
3:20     Break
3:40     Herpes Zoster (HZ)
         · Introduction                                                                      Dr. Paul Cieslak (ACIP, WG Chair)
         · Background regarding HZ and HZ vaccine                                            Dr. Rafael Harpaz (CDC/NCIRD)
         · Field effectiveness of HZ vaccine in persons 60 years of                          Dr. Hung Fu Tseng (Southern California Kaiser Permanente)
         age and older
         · Update: HZ vaccine safety: VAERS & VSD data                                       Dr. Zanie Leroy (CDC/NCEZID); Dr. Hung Fu Tseng
                                                                      Information &          (SCKP)
         · Results of phase 4 safety study of HZ vaccine                Discussion           Dr. Janie Parrino (Merck)
         · Efficacy of HZ vaccine in persons 50-59 years of age                              Dr. Janie Parrino (Merck)

         · Safety and immunogenicity of HZ vaccine in persons 50-                            Dr. Janie Parrino (Merck)
         59 years of age
5:20     Vaccine Supply                                                Information           Dr. Jeanne Santoli (CDC/NCIRD)

5:30     Public Comments
5:45     Adjourn


                                                                                                                                              page 1 of 2
                                                          FINAL - February 16, 2011
                             MEETING OF THE ADVISORY COMMITTEE ON IMMUNIZATION PRACTICES (ACIP)
                                                       Centers for Disease Control and Prevention
                             1600 Clifton Road, NE, Tom Harkin Global Communications Center (Building 19), Atlanta, Georgia
                                                                  February 23-24, 2011
        AGENDA ITEM                                                   PURPOSE                     PRESIDER/PRESENTER(s)


Thursday, February 24,
8:00   Unfinished Business                                                                        Dr. Carol Baker (Chair, ACIP)

8:15     Evidence Based Recommendations
         · Update on EB recommendation implementation                 Information                 Dr. Jon Temte (ACIP, WG Chair)

8:20     Immunization in the United Kingdom
                                                                                                  Dr. David Salisbury (Department of Health, United
         · Immunization coverage levels in the United Kingdom         Information
                                                                                                  Kingdom)

8:50     Human Papillomavirus Vaccines (HPV)
         · Introduction and HPV epidemiology overview                                             Dr. Eileen Dunne (CDC/NCHHSTP)
         · Update on HPV-related cancers                              Information                 Dr. Mona Saraiya (CDC/NCCDPHP)
         · Anal HPV infection and cancer                                   &                      Dr. Joel Palefsky (UCSF)
         · Cost effectiveness updates and review                       Discussion                 Dr. Harrell Chesson (CDC/NCHHSTP)
         · HPV Work Group plans                                                                   Dr. Lauri Markowitz (CDC/NCHHSTP)
10:00    Break

10:30    Hepatitis B Vaccine
         · Update: Work Group activities                                                          Dr. Mark Sawyer (ACIP, WG Chair)
         · Update: diabetes mellitus statistics                      Information &                Ms. Nilka Burrows (CDC/NCCDPHP)
         · Hepatitis B incidence and diabetes mellitus                 Discussion                 Ms. Meredith Reilly (CDC/NCHHSTP)
         · Next steps                                                                             Dr. Trudy Murphy (CDC/NCHHSTP)

11:30    13-valent Pneumococcal Conjugate Vaccine (PCV13)
         · Introduction                                                                           Dr. Mike Marcy (ACIP, WG Chair)
         · Safety and immunogenicity of PCV13 in adults                                           Dr. Peter Paradiso (Pfizer)
         · Cost-effectiveness of PCV13 vaccination of adults ≥50                                  Dr. Richard Zimmerman (University of Pittsburgh), Dr.
                                                                     Information &
         years of age                                                                             Kenneth Smith (University of Pittsburgh)
                                                                       Discussion
         · Public health and economic impact of PCV13 in US                                       Dr. David Strutton (Pfizer)
         adults ≥50 years of age

1:00     Public comment

1:15     Adjourn


                                           Acronyms
         HZ                    Herpes Zoster
         NCCDPHP               National Center for Chronic Disease Prevention and Health
         NCEZID                National Center for Emerging and Zoonotic Infectious Diseases
         NCHHSTP               National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention
         NCIRD                 National Center for Immunization and Respiratory Diseases
         TBD                   To be determined
         Tdap                  Tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine
         UCSF                  University of California, San Francisco
         VAERS                 Vaccine Adverse Event Reporting System
         VSD                   Vaccine Safety Datalink
         WG                    Work Group




  This document can be found on the CDC website at:
  http://www.cdc.gov/vaccines/recs/acip/downloads/agenda-feb11.pdf



                                                                                                                                                      page 2 of 2

								
To top